We are live on ! Find out more
TEE

Tibra Equities Europe Portfolio holdings

AUM $90.4M
1-Year Est. Return 37.81%
This Fund
S&P 500
This Quarter Est. Return
-1.84%
1 Year Est. Return
+37.81%
3 Year Est. Return
+142.96%
5 Year Est. Return
10 Year Est. Return
AUM
$65M
AUM Growth
-$259M
Cap. Flow
-$258M
Cap. Flow %
-397.4%
Top 10 Hldgs %
84.7%
Holding
272
New
32
Increased
2
Reduced
3
Closed
235

Sector Composition

Rank Sector Weight
1 Communication Services 22.97%
2 Materials 11.76%
3 Utilities 6.05%
4 Technology 4.78%
5 Financials 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPOK icon
176
Spok Holdings
SPOK
$241M
-35,100
Closed -$338K
STRS icon
177
Stratus Properties
STRS
$154M
-12,600
Closed -$311K
SVRA icon
178
Savara
SVRA
$1.19B
-189,800
Closed -$323K
TELA icon
179
TELA Bio
TELA
$38.9M
-12,900
Closed -$208K
TLPH icon
180
Talphera
TLPH
$74.2M
-12,320
Closed -$340K
TSBK icon
181
Timberland Bancorp
TSBK
$351M
-11,900
Closed -$335K
UBFO
182
DELISTED
United Security Bancshares
UBFO
-24,900
Closed -$203K
UBX
183
DELISTED
Unity Biotechnology
UBX
-8,070
Closed -$374K
ULBI icon
184
Ultralife
ULBI
$106M
-39,300
Closed -$329K
UNTY icon
185
Unity Bancorp
UNTY
$599M
-13,400
Closed -$295K
UTI icon
186
Universal Technical Institute
UTI
$1.59B
-56,100
Closed -$364K
VERO
187
DELISTED
Venus Concept
VERO
-496
Closed -$255K
VERU icon
188
Veru
VERU
$37.4M
-2,950
Closed -$238K
VNRX icon
189
VolitionRx Ltd
VNRX
$9.34M
-4,250
Closed -$280K
VYGR icon
190
Voyager Therapeutics
VYGR
$201M
-76,000
Closed -$314K
YARW
191
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
-101
Closed -$319K
WEYS icon
192
Weyco Group
WEYS
$440M
-10,800
Closed -$242K
WHG icon
193
Westwood Holdings Group
WHG
$190M
-15,400
Closed -$335K
WNEB icon
194
Western New England Bancorp
WNEB
$275M
-39,600
Closed -$323K
WTW icon
195
Willis Towers Watson
WTW
$32B
-155,102
Closed -$35.7M
XAIR icon
196
Beyond Air
XAIR
$3.86M
-127
Closed -$329K
XCUR icon
197
Exicure
XCUR
$8.54M
-1,183
Closed -$266K
XFOR icon
198
X4 Pharmaceuticals
XFOR
$460M
-1,613
Closed -$315K
XME icon
199
State Street SPDR S&P Metals & Mining ETF
XME
$4.48B
-17,643
Closed -$760K
XRT icon
200
State Street SPDR S&P Retail ETF
XRT
$654M
-49,699
Closed -$4.83M

Similar funds

Tibra Equities Europe's Q3 2021 Portfolio in Review

As of Q3 2021, Tibra Equities Europe held 272 positions worth $65M, down 80% from $324M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Tibra Equities Europe withdrew a net $258M in Q3 2021, closing 235 positions and reducing 3 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $37.6M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 23% of assets, up from 14% a quarter earlier, followed by Materials and Utilities.

Against the trend, Tibra Equities Europe opened a new position in DOMTAR CORPORATION (New) worth $6.46M.

  • Tibra Equities Europe's largest Q3 2021 buy was DOMTAR CORPORATION (New): 118,493 shares worth $6.46M.
  • Tibra Equities Europe added most to iShares Russell 2000 ETF in Q3 2021, an estimated $16.9M increase.
  • Tibra Equities Europe's biggest Q3 2021 reduction was IHS Markit Ltd. Common Shares, cutting an estimated $22.6M.
  • Tibra Equities Europe fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $37.6M.
  • Tibra Equities Europe's ten largest holdings make up 85% of its $65M portfolio in Q3 2021.
  • Tibra Equities Europe opened 32 new positions and closed 235 in Q3 2021.
  • Tibra Equities Europe's portfolio value fell 80% quarter-over-quarter to $65M.

Based on Tibra Equities Europe's 13F filing for Q3 2021, filed 15 Nov 2021.